KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Short-Term Debt issuances (2017 - 2025)

Historic Short-Term Debt issuances for BeOne Medicines (ONC) over the last 7 years, with Q2 2025 value amounting to $141.5 million.

  • BeOne Medicines' Short-Term Debt issuances fell 2240.49% to $141.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $765.4 million, marking a year-over-year decrease of 703.84%. This contributed to the annual value of $868.3 million for FY2024, which is 3125.18% up from last year.
  • BeOne Medicines' Short-Term Debt issuances amounted to $141.5 million in Q2 2025, which was down 2240.49% from $80.0 million recorded in Q1 2025.
  • BeOne Medicines' Short-Term Debt issuances' 5-year high stood at $543.9 million during Q4 2024, with a 5-year trough of $768000.0 in Q3 2023.
  • Over the past 5 years, BeOne Medicines' median Short-Term Debt issuances value was $99.5 million (recorded in 2021), while the average stood at $144.5 million.
  • Examining YoY changes over the last 5 years, BeOne Medicines' Short-Term Debt issuances showed a top increase of 82031.16% in 2023 and a maximum decrease of 9920.16% in 2023.
  • Over the past 5 years, BeOne Medicines' Short-Term Debt issuances (Quarter) stood at $102.9 million in 2021, then skyrocketed by 45.79% to $150.0 million in 2022, then skyrocketed by 232.61% to $498.9 million in 2023, then grew by 9.01% to $543.9 million in 2024, then crashed by 73.98% to $141.5 million in 2025.
  • Its Short-Term Debt issuances stands at $141.5 million for Q2 2025, versus $80.0 million for Q1 2025 and $543.9 million for Q4 2024.